Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
9
×
national blog main
biotech
life sciences
san francisco blog main
boston top stories
boston
clinical trials
fda
startups
deals
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco top stories
indiana blog main
investing
medical device
national
seattle blog main
vc
venture capital
biotech ipos
boulder/denver blog main
cancer
cancer diagnostics
detroit blog main
drug delivery
freenome
grail
ipo
liquid biopsy
medtech
new york top stories
novartis
raleigh-durham top stories
rare disease drugs
roboticsai
san diego top stories
What
developing
9
×
company
ipo
medicines
tests
therapeutics
blood
million
new
based
biotech
cancer
drug
fda
investors
plans
public
raised
startup
treat
activity
affects
aims
americans
announced
approach
approvals
approved
area
bay
beta
bio
biogen
bionics
biopsy
brings
broader
buildout
business
called
Language
unset
Current search:
developing
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation